Company Filing History:
6 out of 4,447 
1 out of 832,880 Years Active: 1994-2004
Title: Innovations and Contributions of Rama M Belagaje
Introduction
Rama M Belagaje is a notable inventor based in Indianapolis, IN (US), recognized for his significant contributions to the field of biotechnology. With a total of seven patents to his name, he has made remarkable advancements in the development of novel biotechnological solutions.
Latest Patents
Among his latest patents is the invention of recombinant baculoviruses producing insect toxins. This innovative approach involves a recombinant baculovirus that is equipped with a genetic coding sequence for the production of a foreign protein toxic to insects. The preferred embodiments include nuclear polyhedrosis viruses, specifically BmNPV.AaIT and AcNPV.AaIT, which function effectively in insect cells. The toxin AaIT, derived from scorpion venom, is secreted in infected insect cells. Additionally, he has developed a patent for a metabotropic glutamate receptor 4 nucleic acid, which describes a novel human glutamate receptor designated mGluR4. This invention encompasses nucleic acids encoding this receptor and methods employing this receptor and its nucleic acid compounds.
Career Highlights
Rama M Belagaje has had a distinguished career, working with prominent organizations such as Eli Lilly and Company. His work has significantly impacted the field of biotechnology, particularly in the development of insecticidal proteins and receptor technologies.
Collaborations
Throughout his career, he has collaborated with notable colleagues, including Su Wu and Richard Dennis DiMarchi. These collaborations have further enhanced his research and innovation efforts.
Conclusion
Rama M Belagaje's contributions to biotechnology through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to influence advancements in insect control and receptor technology.